Compounds > 2,4-diamino-5-adamantyl-6-methylpyrimidine
Page last updated: 2024-08-24

2,4-diamino-5-adamantyl-6-methylpyrimidine and Prostatic Neoplasms

2,4-diamino-5-adamantyl-6-methylpyrimidine has been researched along with Prostatic Neoplasms in 1 studies

*Prostatic Neoplasms: Tumors or cancer of the PROSTATE. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mittelman, A1

Other Studies

1 other study(ies) available for 2,4-diamino-5-adamantyl-6-methylpyrimidine and Prostatic Neoplasms

ArticleYear
New agents for prostatic carcinoma.
    Urology, 1981, Volume: 17, Issue:4 Suppl

    Topics: Adamantane; Alkylating Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Estramustine; Fluorouracil; Humans; Male; Prostatic Neoplasms

1981